AstraZeneca therapy for clearing protein deposits fails main goal in late-stage study
AstraZeneca therapy for clearing protein deposits fails main goal in late-stage studySource: Reuters
التصنيف Investing News
أخبار الاستثمار والأسواق المالية من موقع Investing.com
Exclusive-Universal’s $775 million Downtown bid faces EU antitrust investigation, sources say
Exclusive-Universal's $775 million Downtown bid faces EU antitrust investigation, sources saySource: Reuters
Barclays turns cautious on European Steel, downgrades ArcelorMittal, Outokumpu
Barclays turns cautious on European Steel, downgrades ArcelorMittal, OutokumpuSource: Investing.com
Japan’s Kawasaki Kisen prepared to reroute more ships away from US over tariffs, CEO says
Japan's Kawasaki Kisen prepared to reroute more ships away from US over tariffs, CEO saysSource: Reuters
AstraZeneca’s anselamimab treatment fails to meet main trial goal; shares slip
AstraZeneca’s anselamimab treatment fails to meet main trial goal; shares slipSource: Investing.com
Asian bonds see first monthly foreign outflow in five months
Asian bonds see first monthly foreign outflow in five monthsSource: Reuters
ASML CFO says easing of US chip export restrictions to China positive
ASML CFO says easing of US chip export restrictions to China positiveSource: Investing.com
Richemont reports 6% rise in sales as jewellery defies luxury slowdown
Richemont reports 6% rise in sales as jewellery defies luxury slowdownSource: Reuters
Fuchs SE lowers guidance amid weak economic environment
Fuchs SE lowers guidance amid weak economic environmentSource: Investing.com
Renault shares tumble 16% after guidance cut, interim CEO appointment
Renault shares tumble 16% after guidance cut, interim CEO appointmentSource: Reuters
تواصل معنا اليوم لبدء إجراءات توثيق معاملتك المالية
الموقع الرسمي:
www.taxtct.com
واتساب واتصال مباشر
+44 7480 219471
البريد الإلكتروني
info@taxtct.com
جميع الحقوق محفوظة ©
All rights reserved ©